ClinicalTrials.gov
ClinicalTrials.gov Menu

Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01429883
Recruitment Status : Completed
First Posted : September 7, 2011
Last Update Posted : June 3, 2015
Sponsor:
Information provided by (Responsible Party):
University of Zurich

September 5, 2011
September 7, 2011
June 3, 2015
July 2011
January 2015   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01429883 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?
Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?
Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get the shock wave therapy in our clinic as planned. During our study the investigators want to ask for pain, pain reduction and function.
Patients with either Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get a shock wave therapy in our clinic of rheumatology as planned. During our study the investigators ask for pain, pain reduction and function (all questionnaires).
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii, who got the shock wave therapy.
  • Fasciitis, Plantar
  • Achillodynia
  • Periarthritis Calcarea
  • Epikondylopathia Humeri /Radii
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
36
100
January 2015
January 2015   (Final data collection date for primary outcome measure)

Inclusion criteria:

-Patients with:

  • Fascititis plantaris,
  • Achillodynie,
  • Periarthropathia humerosacpularis calcarea or
  • Epicondylopathia humeri /radii, who got the shock wave therapy.

Exclusion criteria:

  • Anticoagulation,
  • Sepsis
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
 
NCT01429883
ESWTRUZ01
Yes
Not Provided
Not Provided
University of Zurich
University of Zurich
Not Provided
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
Principal Investigator: Sandra Blumhardt, MD University Hospital Zurich, Division of Rheumatology
University of Zurich
May 2015